x

Welcome to Merck Chemicals

 

Please choose your country:

North America

Latin America

Europe

Africa

Asia / Pacific

All countries from A to Z

If you can't find your country please click here.

Logo Merck KGaA
Merck4Biosciences | International

Important message


It is currently not possible to order Bioscience products together with other Merck products. We recommend completing your current order first.

Do you wish to proceed without completing your current order? If so, this will empty your shopping cart.


Information
X


Merck4Biosciences

Novabiochem

Novagen

Calbiochem


365250  Gö 6976

Go 6976, 12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole

A cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC; IC50 = 7.9 nM for rat brain). Selectively inhibits Ca2+-dependent PKC α-isozyme (IC50 = 2.3 nM) and PKCβI (IC50 = 6.2 nM). Does not affect the kinase activity of the Ca2+-independent PKC δ-, ε-, and ζ-isozymes even at micromolar levels. Reported to inhibit PKCµ at higher concentrations (IC50 = 20 nM). A 500 µg/ml solution of Gö 6976 (Cat. No. 365253) in anhydrous DMSO is also available.
Product number Size Quantity Price
365250-500UG  500 μg  price on request 
Product information
Form Off-white solid
Primary Target PKC
Primary Target IC50 7.9 nM
Secondary target Ca2+-dependent PKC α-isozyme (IC50 = 2.3 nM) and PKCβI (IC50 = 6.2 nM) , PKCµ at higher concentrations IC50 = 20 nM
Molar mass 378.4
Protect from Light Yes
Purity ≥95% by HPLC
Solubility DMSO
Chemical formula C24H18N4O
CAS number 136194-77-9
Declaration Sold under license of U.S. Patent 5,489,608 and European Patent 0,434,057.
Store and ship information
Storage +2°C to +8°C
Ship Ambient Temperature Only
Standard Handling
Gö 6976, molecular structure

Top

© Merck KGaA, Darmstadt, Germany, 2010